Network pharmacology study on the mechanism of the Chinese medicine Radix Isatidis (Banlangen) for COVID-19. Issue 32 (13th August 2021)
- Record Type:
- Journal Article
- Title:
- Network pharmacology study on the mechanism of the Chinese medicine Radix Isatidis (Banlangen) for COVID-19. Issue 32 (13th August 2021)
- Main Title:
- Network pharmacology study on the mechanism of the Chinese medicine Radix Isatidis (Banlangen) for COVID-19
- Authors:
- Yu, Bin
Lin, Fei
Ning, Hong
Ling, Baodong - Other Names:
- Cruz. Jorddy Neves section editor.
- Abstract:
- Abstract : Abstract: Radix Isatidis (Banlangen) is a well-known traditional Chinese medicine for the treatment of different diseases and prevention of many body disorders. Besides, it also plays a pivotal role in novel coronavirus pneumonia, coronavirus disease 2019 (COVID-19). However, few researchers know its active ingredients and mechanism of action for COVID-19. To find whether Banlangen has a pharmacological effect on COVID-19. In this research, we systematically analyze Banlangen and COVID-19 through network pharmacology technology. A total of 33 active ingredients in Banlangen, 92 targets of the active ingredients, and 259 appropriate targets of COVID-19 were obtained, with 11 common targets. The analysis of the biological process of gene ontology and the enrichment of Kyoto Encyclopedia of Genes and Genomes signaling pathway suggests that Banlangen participated in the biological processes of protein phosphatase binding, tetrapyrrole binding, the apoptotic process involving cysteine-type endopeptidase activity, etc. The COVID-19 may be treated by regulating advanced glycation end products/a receptor for advanced glycation end products signaling pathway, interleukin-17 signaling pathway, tumor necrosis factor signaling pathway, sphingolipid signaling pathway, and p53 signaling pathway. Banlangen has a potential pharmacological effect on COVID-19, which has the value of further exploration in the following experiment and clinical application.
- Is Part Of:
- Medicine. Volume 100:Issue 32(2021)
- Journal:
- Medicine
- Issue:
- Volume 100:Issue 32(2021)
- Issue Display:
- Volume 100, Issue 32 (2021)
- Year:
- 2021
- Volume:
- 100
- Issue:
- 32
- Issue Sort Value:
- 2021-0100-0032-0000
- Page Start:
- Page End:
- Publication Date:
- 2021-08-13
- Subjects:
- Banlangen -- COVID-19 -- network pharmacology
Medicine -- Periodicals
Medicine -- Periodicals
Médecine -- Périodiques
Geneeskunde
Medicine
Periodicals
Periodicals
610.5 - Journal URLs:
- http://journals.lww.com/md-journal/pages/default.aspx ↗
http://gateway.ovid.com/ovidweb.cgi?T=JS&PAGE=toc&D=ovft&MODE=ovid&NEWS=N&AN=00002060-000000000-00000 ↗
http://journals.lww.com ↗ - DOI:
- 10.1097/MD.0000000000026881 ↗
- Languages:
- English
- ISSNs:
- 0025-7974
- Deposit Type:
- Legaldeposit
- View Content:
- Available online (eLD content is only available in our Reading Rooms) ↗
- Physical Locations:
- British Library DSC - 5534.000000
British Library DSC - BLDSS-3PM
British Library STI - ELD Digital store - Ingest File:
- 18918.xml